EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Lines on the line: evaluating the impact of antibiotic lock therapy versus catheter removal in the management of central vascular catheter infections

Nischal Ranganath iD, Hussam Tabaja, Vaisak O Nair, Mitchell Dumais, Ryan W Stevens iD, Dalton Kind, Allison Lemahieu, John O'Horo, Aditya Shah iD

Journal of Antimicrobial Chemotherapy · 01.07.2025 · 80 (7) · 2016-2024

DOI: 10.1093/jac/dkaf168 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 05.06.2025. Verfasst von Nischal Ranganath und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Catheter-Related Infections, Anti-Bacterial Agents, Device Removal, Central Venous Catheters. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the efficacy and safety of antibiotic lock therapy (ALT) versus catheter removal in managing central vascular catheter–associated bloodstream infection (CVC-BSI).

Methods

We conducted a single-centre, retrospective cohort study of adult patients treated with ALT or catheter removal for management of CVC-BSI between 2018 and 2022. The primary outcome was a composite of 90 day microbiological relapse or recurrent BSI. Secondary outcomes included 30 day mortality, CVC-associated complications and Clostridioides difficile infection (CDI). Logistic regression with propensity score-adjustment was used to evaluate differences in outcomes and identify predictors of relapse.

Results

During the study period, 106 participants received ALT and 181 underwent catheter removal. Patients treated with ALT received shorter courses of systemic antimicrobials (11 versus 14 days; P < 0.001) and had shorter hospital stays (4 versus 10 days; P < 0.001). Median duration of catheter salvage in patients receiving ALT was 28 days (IQR 7–80). Primary composite outcome was similar between both groups, but ALT was associated with a significantly higher risk of microbiological relapse within 90 days (20% versus 7%; adjusted odds ratio 3.93, 95% CI 1.64–9.40; P = 0.002). No significant difference in 30 day mortality, CVC-related complications or CDI was observed. CoNS BSI was an independent predictor of microbiological relapse in patients treated with ALT (OR 2.28; P = 0.05).

Conclusions

Although ALT offers a non-invasive catheter salvage strategy, its association with higher relapse rates, particularly in CoNS BSI, suggests catheter removal should remain the preferred approach when feasible. ALT could be considered a short-term catheter salvage strategy for pathogens with low virulence when used with close surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheter-Related InfectionsAnti-Bacterial AgentsDevice RemovalCentral Venous CathetersCatheterization, Central VenousHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomeBacteremiaClostridium InfectionsRecurrenceAdult

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  • Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, College of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Nischal Ranganath, Ryan W Stevens, Aditya Shah

Förderung

  • NCATS NIH HHS
  • NIH
  • National Center for Advancing Translational Sciences

Zitieren

APA

Ranganath, N., Tabaja, H., Nair, V. O., Dumais, M., Stevens, R. W., Kind, D., Lemahieu, A., O'Horo, J., & Shah, A. (2025). Lines on the line: evaluating the impact of antibiotic lock therapy versus catheter removal in the management of central vascular catheter infections. Journal of Antimicrobial Chemotherapy, 80(7), 2016-2024. https://doi.org/10.1093/jac/dkaf168

Vancouver

Ranganath N, Tabaja H, Nair VO, Dumais M, Stevens RW, Kind D, et al. Lines on the line: evaluating the impact of antibiotic lock therapy versus catheter removal in the management of central vascular catheter infections. Journal of Antimicrobial Chemotherapy. 2025;80(7):2016-2024. doi:10.1093/jac/dkaf168

BibTeX
@article{Ranganath2025,
  author = {Ranganath, Nischal and Tabaja, Hussam and Nair, Vaisak O and Dumais, Mitchell and Stevens, Ryan W and Kind, Dalton and Lemahieu, Allison and O'Horo, John and Shah, Aditya},
  title = {Lines on the line: evaluating the impact of antibiotic lock therapy versus catheter removal in the management of central vascular catheter infections},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {7},
  pages = {2016--2024},
  doi = {10.1093/jac/dkaf168}
}
Kostenlos starten →